Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Federica Galvagno"'
Autor:
Federica Maione, Daniele Oddo, Federica Galvagno, Chiara Falcomatà, Marta Pandini, Marco Macagno, Valeria Pessei, Ludovic Barault, Chiara Gigliotti, Alessia Mira, Giorgio Corti, Simona Lamba, Chiara Riganti, Barbara Castella, Massimo Massaia, Roland Rad, Dieter Saur, Alberto Bardelli, Federica Di Nicolantonio
Publikováno v:
Molecular Oncology, Vol 18, Iss 6, Pp 1552-1570 (2024)
Serine/threonine‐protein kinase B‐raf (BRAF) mutations are found in 8–15% of colorectal cancer patients and identify a subset of tumors with poor outcome in the metastatic setting. We have previously reported that BRAF‐mutant human cells disp
Externí odkaz:
https://doaj.org/article/7e190158690941cbb8123e09efd82413
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2628 (2022)
The outbreak of novel coronavirus disease 2019 (COVID-19) has exacted a disproportionate toll on cancer patients. The effects of anticancer treatments and cancer patients’ characteristics shared significant responsibilities for this dismal outcome;
Externí odkaz:
https://doaj.org/article/dfd425b38fb74cd39d66c5c73b36f734
Autor:
Erika Fiorino, Alessandra Merlini, Lorenzo D’Ambrosio, Ilaria Cerviere, Enrico Berrino, Caterina Marchiò, Lidia Giraudo, Marco Basiricò, Annamaria Massa, Chiara Donini, Valeria Leuci, Ramona Rotolo, Federica Galvagno, Letizia Vitali, Alessia Proment, Soldano Ferrone, Alberto Pisacane, Ymera Pignochino, Massimo Aglietta, Giovanni Grignani, Giulia Mesiano, Dario Sangiolo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 18, p 10368 (2022)
Gastrointestinal stromal tumors (GISTs) are rare, mesenchymal tumors of the gastrointestinal tract, characterized by either KIT or PDGFRA mutation in about 85% of cases. KIT/PDGFRA wild type gastrointestinal stromal tumors (wtGIST) account for the re
Externí odkaz:
https://doaj.org/article/9b6da69e1c014df084fb603feb30f0ad
Autor:
Ramona Rotolo, Valeria Leuci, Chiara Donini, Federica Galvagno, Annamaria Massa, Maria Chiara De Santis, Serena Peirone, Giovanni Medico, Martina Sanlorenzo, Igor Vujic, Loretta Gammaitoni, Marco Basiricò, Luisella Righi, Chiara Riganti, Iris Chiara Salaroglio, Francesca Napoli, Fabrizio Tabbò, Annapaola Mariniello, Elisa Vigna, Chiara Modica, Lorenzo D’Ambrosio, Giovanni Grignani, Riccardo Taulli, Emilio Hirsch, Matteo Cereda, Massimo Aglietta, Giorgio Vittorio Scagliotti, Silvia Novello, Paolo Bironzo, Dario Sangiolo
Publikováno v:
Clinical Cancer Research. 29:621-634
Purpose: Antibodies against the lymphocyte PD-1 (aPD-1) receptor are cornerstone agents for advanced non–small cell lung cancer (NSCLC), based on their ability to restore the exhausted antitumor immune response. Our study reports a novel, lymphocyt
Autor:
Paola Circosta, Chiara Donini, Susanna Gallo, Lidia Giraudo, Loretta Gammaitoni, Ramona Rotolo, Federica Galvagno, Sonia Capellero, Marco Basiricò, Monica Casucci, Massimo Aglietta, Ivana Ferrero, Franca Fagioli, Alessandro Cignetti, Fabrizio Carnevale‐Schianca, Valeria Leuci, Dario Sangiolo
Publikováno v:
British Journal of Haematology. 200:64-69
Autor:
Dario Sangiolo, Paolo Bironzo, Silvia Novello, Giorgio Vittorio Scagliotti, Massimo Aglietta, Matteo Cereda, Emilio Hirsch, Riccardo Taulli, Giovanni Grignani, Lorenzo D’Ambrosio, Chiara Modica, Elisa Vigna, Annapaola Mariniello, Fabrizio Tabbò, Francesca Napoli, Iris Chiara Salaroglio, Chiara Riganti, Luisella Righi, Marco Basiricò, Loretta Gammaitoni, Igor Vujic, Martina Sanlorenzo, Giovanni Medico, Serena Peirone, Maria Chiara De Santis, Annamaria Massa, Federica Galvagno, Chiara Donini, Valeria Leuci, Ramona Rotolo
PD-L1/2 and phospho-p38 MAPK expression in NSCLC cells. Tumor membrane expression of PD-L1 and PD-L2 in NSCLC cell lines was intensely enhanced by treatment with Interferon γ (n=9, PD-L1 p=0.02, PD-L2 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b6ec0bb3274f7c4bc99b140f2b8f43f
https://doi.org/10.1158/1078-0432.22489961.v1
https://doi.org/10.1158/1078-0432.22489961.v1
Autor:
Dario Sangiolo, Paolo Bironzo, Silvia Novello, Giorgio Vittorio Scagliotti, Massimo Aglietta, Matteo Cereda, Emilio Hirsch, Riccardo Taulli, Giovanni Grignani, Lorenzo D’Ambrosio, Chiara Modica, Elisa Vigna, Annapaola Mariniello, Fabrizio Tabbò, Francesca Napoli, Iris Chiara Salaroglio, Chiara Riganti, Luisella Righi, Marco Basiricò, Loretta Gammaitoni, Igor Vujic, Martina Sanlorenzo, Giovanni Medico, Serena Peirone, Maria Chiara De Santis, Annamaria Massa, Federica Galvagno, Chiara Donini, Valeria Leuci, Ramona Rotolo
Treatment with PD-L1s is associated with the up-regulation of expression of key protein coding genes involved in processes of tumorigenesis, EMT, tumor aggressiveness and chemoresistance. Heatmap showing z-scaled DESeq2-normalized expression values o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51261ae562e9aeda6258ca8dca6fdd30
https://doi.org/10.1158/1078-0432.22489964.v1
https://doi.org/10.1158/1078-0432.22489964.v1
Autor:
Dario Sangiolo, Paolo Bironzo, Silvia Novello, Giorgio Vittorio Scagliotti, Massimo Aglietta, Matteo Cereda, Emilio Hirsch, Riccardo Taulli, Giovanni Grignani, Lorenzo D’Ambrosio, Chiara Modica, Elisa Vigna, Annapaola Mariniello, Fabrizio Tabbò, Francesca Napoli, Iris Chiara Salaroglio, Chiara Riganti, Luisella Righi, Marco Basiricò, Loretta Gammaitoni, Igor Vujic, Martina Sanlorenzo, Giovanni Medico, Serena Peirone, Maria Chiara De Santis, Annamaria Massa, Federica Galvagno, Chiara Donini, Valeria Leuci, Ramona Rotolo
Double positive OCT3/4-PD1 subsets in the bulk NSCLC cells after cisplatin treatment. OCT3/4 expression preferentially co-localized on PD-1+ NSCLC cells as compared with the PD-1- counterpart (14% vs 0.1%). Representative flow cytometry histograms of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8bee94264097ec1c6030380045f780
https://doi.org/10.1158/1078-0432.22489967.v1
https://doi.org/10.1158/1078-0432.22489967.v1
Autor:
Paola, Circosta, Chiara, Donini, Susanna, Gallo, Lidia, Giraudo, Loretta, Gammaitoni, Ramona, Rotolo, Federica, Galvagno, Sonia, Capellero, Marco, Basiricò, Monica, Casucci, Massimo, Aglietta, Ivana, Ferrero, Franca, Fagioli, Alessandro, Cignetti, Fabrizio, Carnevale-Schianca, Valeria, Leuci, Dario, Sangiolo
Cytokine-induced killer lymphocytes (CIK) are a promising alternative to conventional donor lymphocyte infusion (DLI), following allogeneic haematopoietic cell transplantation (HCT), due to their intrinsic anti-tumour activity and reduced risk of gra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::670198723b323b780aed1a4131d4f912
https://hdl.handle.net/2318/1878042
https://hdl.handle.net/2318/1878042
Autor:
Annamaria Massa, Valeria Leuci, Federica Galvagno, Chiara Donini, Francesca Vita, Ramona Rotolo, Alessia Proment, Letizia Vitali, Elisabetta Fenocchio, Elisa Vigna, Giuliana Cavalloni, Massimo Aglietta, Dario Sangiolo
Publikováno v:
Regular and Young Investigator Award Abstracts.